Colossal Biosciences, known for its outlandish goal to resurrect the woolly mammoth by 2028, is claiming steady progress. It’s evidence: Genetically engineering mice to have mammoth-like fur. To engineer the woolly mouse, the company’s scientists found mouse versions of mammoth genes and then used CRISPR to edit mice embryos, Dr. Beth Shapiro, chief science officer…
Category: Colossal Biosciences
Biotech & Health, Climate, Colossal Biosciences, CRISPR, de-extinction tech, Global IT News, Global Security News, Startups, synthetic biology
Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths
Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it. © 2024 TechCrunch. All rights reserved. For personal use only.